145 related articles for article (PubMed ID: 28708445)
1. Evaluation of YAP signaling in a rat tympanic membrane under a continuous negative pressure load and in human middle ear cholesteatoma.
Akiyama N; Yamamoto-Fukuda T; Yoshikawa M; Kojima H
Acta Otolaryngol; 2017 Nov; 137(11):1158-1165. PubMed ID: 28708445
[TBL] [Abstract][Full Text] [Related]
2. L1CAM-ILK-YAP Mechanotransduction Drives Proliferative Activity of Epithelial Cells in Middle Ear Cholesteatoma.
Yamamoto-Fukuda T; Akiyama N; Kojima H
Am J Pathol; 2020 Aug; 190(8):1667-1679. PubMed ID: 32360569
[TBL] [Abstract][Full Text] [Related]
3. Influence of continuous negative pressure in the rat middle ear.
Akiyama N; Yamamoto-Fukuda T; Takahashi H
Laryngoscope; 2014 Oct; 124(10):2404-10. PubMed ID: 24916143
[TBL] [Abstract][Full Text] [Related]
4. Gerbilline cholesteatoma development. Part II: temporal histopathologic changes in the tympanic membrane and middle ear.
Tinling SP; Chole RA
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):953-60. PubMed ID: 16730537
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
Yamamoto-Fukuda T; Akiyama N
Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
[TBL] [Abstract][Full Text] [Related]
6. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
7. [Proliferative potential of the ear drum in the process of gerbiline cholesteatoma formation].
Shimoya S; Makino K; Omura F; Amatsu M
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):1029-37. PubMed ID: 9778949
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.
Zeng L; Xie L; Hu J; He C; Liu A; Lu X; Zhou W
Cell Cycle; 2024 Mar; 23(5):537-554. PubMed ID: 38662954
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of retraction pocket pars tensa of tympanic membrane in children.
Urík M; Hurník P; Žiak D; Machač J; Šlapák I; Motyka O; Jabandžiev P
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():111-116. PubMed ID: 30999159
[TBL] [Abstract][Full Text] [Related]
10. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
Park K; Chun YM; Park HJ; Lee YD
Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
[TBL] [Abstract][Full Text] [Related]
12. Does occurrence of keratinizing stratified squamous epithelium in the middle-ear cavity always indicate a cholesteatoma?
Stenfors LE
J Laryngol Otol; 2004 Oct; 118(10):757-63. PubMed ID: 15550180
[TBL] [Abstract][Full Text] [Related]
13. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
[TBL] [Abstract][Full Text] [Related]
15. The spatial organisation of keratinocytes in acquired middle ear cholesteatoma resembles that of external auditory canal skin and pars flaccida.
Youngs R; Rowles P
Acta Otolaryngol; 1990; 110(1-2):115-9. PubMed ID: 2386026
[TBL] [Abstract][Full Text] [Related]
16. The role of middle ear effusions and epidermal growth factor in cholesteatoma formation in the gerbilline temporal bone.
Omura F; Makino K; Amatsu M; Itoh H
Eur Arch Otorhinolaryngol; 1995; 252(7):428-32. PubMed ID: 8562039
[TBL] [Abstract][Full Text] [Related]
17. Congenital cholesteatomas in the tympanic membrane.
Weber PC; Adkins WY
Laryngoscope; 1997 Sep; 107(9):1181-4. PubMed ID: 9292600
[TBL] [Abstract][Full Text] [Related]
18. Attic cholesteatoma with closure of the entrance to pars flaccida retraction pocket.
Matsuzawa S; Iino Y; Yamamoto D; Hasegawa M; Hara M; Shinnabe A; Kanazawa H; Yoshida N
Auris Nasus Larynx; 2017 Dec; 44(6):766-770. PubMed ID: 28041650
[TBL] [Abstract][Full Text] [Related]
19. Expression of involucrin in human middle ear cholesteatoma.
Chao WY; Huang CC
Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
[TBL] [Abstract][Full Text] [Related]
20. Attic cholesteatoma with tiny retraction of pars flaccida.
Lee JH; Hong SM; Kim CW; Park YH; Baek SH
Auris Nasus Larynx; 2015 Apr; 42(2):107-12. PubMed ID: 25199742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
